“Before making this decision, the FDA conducted a thorough review of facility records and the results of quality testing performed by the manufacturer. Based on this review and considering the current COVID-19 public health emergency, the FDA concluded these batches are suitable for use,” the FDA said in a statement.
Kathy Wengel, executive vice president and chief global supply chain officer for Johnson & Johnson, hailed the progress Friday.
“Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, and we appreciate the close…
